Glo-Vision Medicaments Limited
About Glo-Vision Medicaments Limited
Data last updated:
Glo-Vision Medicaments Limited is a public limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PLC140778. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹16.51 Lakh. It is led by directors including Dinesh Parasmal Raka and Parasmal Uttamchand Raka.
Its last annual general meeting (AGM) was held on 26 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at Thane, Maharashtra.
As per MCA filings, the company has open charges of ₹10.37 Cr and satisfied charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Glo-Vision Medicaments Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No.3 Godown Bo.117 1st Floor Arihant Commercial Complex Purna Villag, E Bhiwand, Thane, Maharashtra, India – 421302
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glo-Vision Medicaments Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Glo-Vision Medicaments Limited
FY 2017 filings availableGlo-Vision Medicaments Limited reported revenue of ₹248 (down 100% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 98% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹248 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Glo-Vision Medicaments Limited, buy the company report.
Board of directors of Glo-Vision Medicaments Limited
Glo-Vision Medicaments has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Parasmal Raka | Director | 06 Jun 2003 | 23 Years 4 Months | Current |
| Parasmal Uttamchand Raka Also directs: Starcare India Limited | Additional Director | 06 Jul 2010 | 16 Years 3 Months | Current |
| Manoj Parasmal Raka Also directs: Starcare India Limited | Additional Director | 31 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Glo-Vision Medicaments Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medfly Life Sciences Private Limited | ₹398 (FY 2025) | Pune, Maharashtra, India | ||||
| Spansules Formulations Private Limited | ₹320 (FY 2024) | -100.0% | Hyderabad, Telangana, India | |||
| M C W Pharma Pvt Ltd | ₹311 (FY 2024) | Indore, Madhya Pradesh, India | ||||
| Kalpshri Pharmaceuticals Private Limited | ₹273 (FY 2025) | -100.0% | Noida, Uttar Pradesh, India | |||
| Xoranges Private Limited | ₹256 (FY 2024) | Bangalore, Karnataka, India | ||||
| Glo-Vision Medicaments Limitedthis company | ₹248 (FY 2017) | -100.0% | Thane, Maharashtra, India | |||
| Elder Remedies Limited | ₹224 (FY 2025) | Delhi, India | ||||
| Sudarshan Medicaments Private Limited | ₹206 (FY 2025) | -100.0% | Indore, Madhya Pradesh, India | |||
| Jamkas Pharmaceuticals Private Limited | ₹155 (FY 2023) | Panchkula, Haryana, India | ||||
| Chiron Lifescience Private Limited | ₹150 (FY 2025) | Bangalore, Karnataka, India | ||||
| Medinex Pharmacy Private Limited | ₹106 (FY 2020) | Gurugram, Haryana, India |
To see the full peer comparison of Glo-Vision Medicaments Limited, buy the company report.
Auditor
Glo-Vision Medicaments Limited is audited by J A M S & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J A M S & ASSOCIATES | FY 2017 | 015586C |
Shareholding
The shareholding of Glo-Vision Medicaments Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Glo-Vision Medicaments Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Oct 2012 | 10380696 | Bank of Baroda | ₹4.5 Cr | Open | |
| 09 May 2012 | 10359219 | Bank of Baroda | ₹11.7 Lakh | Open | |
| 27 Jul 2011 | 10305404 | Bank of Baroda | ₹4.5 Cr | Open | |
| 09 Dec 2010 | 10260200 | Idbi Bank Limited | ₹1.25 Cr | Open | |
| 15 Jan 2005 | 90353431 | The Ajantha Urban Co-Op; Bank Ltd. | ₹25 Lakh | Satisfied |
To see the full charge records of Glo-Vision Medicaments Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Glo-Vision Medicaments Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by The State of Maharashtra | Disposed |
To see the full case history of Glo-Vision Medicaments Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glo-Vision Medicaments Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glo-Vision Medicaments has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Glo-Vision Medicaments Limited, buy the company report.
Recent activity
Glo-Vision Medicaments Limited has 6 board changes on record since 2003: 3 appointments and 3 cessations. The latest: Yogita Manoj Raka ceased to be Director on 31 Mar 2014.
4 earlier events are in the company report.
Frequently asked questions
Glo-Vision Medicaments is an active public limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 June 2003 (23+ years old) and is registered under CIN U24230MH2003PLC140778.
Glo-Vision Medicaments has 3 current directors:
- Dinesh Parasmal Raka - Director
- Parasmal Uttamchand Raka - Additional Director
- Manoj Parasmal Raka - Additional Director
The latest financial statements of Glo-Vision Medicaments on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 26 September 2017. Year-wise statements from 2015 are in the company report.
No. Glo-Vision Medicaments has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Glo-Vision Medicaments is U24230MH2003PLC140778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glo-Vision Medicaments has 1 court case on record: 1 filed against it.
Glo-Vision Medicaments was incorporated on 06 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Glo-Vision Medicaments by revenue are Medfly Life Sciences Private Limited, Spansules Formulations Private Limited, M C W Pharma Pvt Ltd, Kalpshri Pharmaceuticals Private Limited, Xoranges Private Limited and 5 more, all in the Pharma industry (Formulations).
Yogita Manoj Raka ceased to be Director on 31 Mar 2014. Parasmal Uttamchand Raka was appointed as Additional Director on 06 Jul 2010. Ratilal Uttamchand Raka ceased to be Director on 06 Jul 2010. Glo-Vision Medicaments has 6 board changes on record in total.
The registered office of Glo-Vision Medicaments is at Building No.3 Godown Bo.117 1st Floor Arihant Commercial Complex Purna Villag, E Bhiwand, Thane, Maharashtra, India – 421302.
Glo-Vision Medicaments operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
